Aditxt (ADTX) Other Working Capital Changes (2020 - 2026)
Aditxt (ADTX) recorded quarterly Other Working Capital Changes of -$294310.0 in Q1 2026, down 153.05% quarter-over-quarter from $554746.0 in Q4 2025, and down 596.83% on a YoY basis from $59237.0 in Q1 2025.
Aditxt (ADTX) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Aditxt's Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$294310.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 596.83% year-over-year to -$294310.0; the TTM figure through Mar 2026 stood at $260436.0 (up 166.06% YoY), while the FY2025 annual figure was $613983.0, up 386.89% from the prior year.
- Other Working Capital Changes was -$294310.0 for Q1 2026 at Aditxt, down from $554746.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $1.4 million in Q3 2023 to a low of -$1.9 million in Q4 2023.
- Historically, Other Working Capital Changes has averaged -$9136.7 across 5 years, with a median of $55475.0 in 2022.
- Biggest YoY gain for Other Working Capital Changes was 1394.65% in 2023; the steepest drop was 10598.12% in 2023.
- A 5-year view of Other Working Capital Changes shows it stood at $17903.0 in 2022, then tumbled by 10598.12% to -$1.9 million in 2023, then jumped by 53.12% to -$881011.0 in 2024, then surged by 162.97% to $554746.0 in 2025, then slumped by 153.05% to -$294310.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$294310.0 (Q1 2026), $554746.0 (Q4 2025), and $59237.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Aditxt | 2,485.68 | -2.16 Mn | 2,868.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -294,310.00 |
| Mar 31, 2026 | -294,310.00 |
| Dec 31, 2025 | 554,746.00 |
| Dec 31, 2025 | 554,746.00 |
| Mar 31, 2025 | 59,237.00 |
| Mar 31, 2025 | 59,237.00 |
| Dec 31, 2024 | -881,011.00 |
| Dec 31, 2024 | -881,011.00 |
| Sep 30, 2024 | 441,102.00 |
| Sep 30, 2024 | 441,102.00 |
| Jun 30, 2024 | -13,596.00 |
| Jun 30, 2024 | -13,596.00 |
| Mar 31, 2024 | 239,494.00 |
| Mar 31, 2024 | 239,494.00 |
| Dec 31, 2023 | -1.88 Mn |
| Dec 31, 2023 | -1.88 Mn |
| Sep 30, 2023 | 1.44 Mn |
| Sep 30, 2023 | 1.44 Mn |
| Jun 30, 2023 | 105,552.00 |
| Jun 30, 2023 | 105,552.00 |